Microdystrophin gene therapy constructs and uses thereof

TW202635888APending Publication Date: 2026-09-01REGENXBIO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146242
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-05-14
Filing Date
2020-11-27
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074757_001
    Figure TWG2TA001074757_001
  • Figure TWG2TA001074757_002
    Figure TWG2TA001074757_002
  • Figure TWG2TA001074757_003
    Figure TWG2TA001074757_003
Patent Text Reader

Abstract

Provided is an invention based, in part, on novel gene constructs that encode a microdystrophin protein for use in gene therapy. The microdystrophin gene constructs and expression cassettes were engineered for improved therapy with respect to efficacy, potency and safety to the subject when expressed by a viral vector in muscle cells and / or CNS cells.
Need to check novelty before this filing date? Find Prior Art